Updates are available Correction dated 2025-05-24

Article History

Received: 13 November 2024

Accepted: 26 February 2025

First Online: 19 March 2025

Change Date: 24 May 2025

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40119-025-00417-5

Declarations

:

: Julian D. Gillmore has acted as an advisor for Alnylam, AstraZeneca, Attralus, BridgeBio, Intellia, Ionis Pharmaceuticals, Inc., and Pfizer. Katrin Hahn has received consulting or speaking honoraria from Akcea, Alnylam, Amicus, AstraZeneca, GSK, Hormosan, Takeda, Pfizer, Swedish Orphan Biovitrum, and ViiV Healthcare, research funding from the foundation Charité (Berlin Institute of Health clinical fellow), Alnylam, and Pfizer, and financial reimbursement for educational activities from the German Society of Neurology. J. Gustav Smith reports that his employer (Gothenburg University) is paid by AstraZeneca for his involvement in ANTHOLOGY (no personal payment). Isabel Conceição has acted as an advisor for Alnylam, AstraZeneca, BridgeBio, Intellia, Ionis Pharmaceuticals, Inc., and Pfizer, and acknowledges financial support as a primary investigator from Pfizer, Alnylam, and Ionis Pharmaceuticals, Inc. Zhuang Tian has no competing interests to declare. Martha Grogan has received research funding from Alnylam, Eidos, Janssen, Novo Nordisk, and Pfizer, and consulting or speaking honoraria from Alnylam, AstraZeneca, BridgeBio, Janssen, and Novo Nordisk. Christina Pao was an employee and shareholder of AstraZeneca at the time of submission. Eric Wittbrodt, Krister Järbrink, and Mia A. Papas are employees of, and hold stock in, AstraZeneca. Margot K. Davis has received consulting or speaking honoraria from AstraZeneca, Ionis Pharmaceuticals, Inc., Novo Nordisk, Bayer, Janssen, Ferring, Pfizer, Alnylam, Anthos, Boehringer Ingelheim/Lilly, and Jazz Pharmaceuticals.

: Both observational studies will adhere to ethical principles that are consistent with the 1964 Declaration of Helsinki and its later amendments, Good Clinical Practices (GCP) guidelines of the International Conference on Harmonization (ICH), Guidelines for Good Pharmacoepidemiology Practices (GPP), and applicable legislation on non-interventional and/or observational studies. The investigators will perform their duties in adherence to local regulations and guidelines governing medical practice and ethics. Local ethics approvals will be obtained for data use where necessary.